Neurogenic Pulmonary Edema (NPE)

1️⃣ Definition

Neurogenic Pulmonary Edema (NPE) is an acute, non-cardiogenic pulmonary edema that develops minutes to hours after a significant central nervous system (CNS) insult, due to massive sympathetic discharge and pulmonary capillary injury.

It is a diagnosis of exclusion in critically ill neurological patients who develop sudden hypoxemia with bilateral infiltrates.


2️⃣ Historical Perspective

NPE was first described after seizures and head injury in the early 20th century. It is now well recognized in:

  • Subarachnoid hemorrhage (SAH)
  • Traumatic brain injury (TBI)
  • Intracerebral hemorrhage (ICH)
  • Status epilepticus
  • Acute spinal cord injury
  • Brainstem lesions


3️⃣ Epidemiology

Incidence varies by neurological insult:

CNS Insult

Incidence of NPE

SAH

10–30%

Severe TBI

20%

Status epilepticus

Variable

Brainstem injury

High risk

Most cases occur within minutes to 4 hours of insult (early NPE), but delayed cases (12–72 hours) can occur.


4️⃣ Pathophysiology 

The mechanism is catecholamine storm + pulmonary capillary injury.

Stepwise Mechanism:

1️⃣ Acute CNS Injury

Intracranial pressure (ICP)
Cerebral perfusion
Brainstem stimulation

2️⃣ Massive Sympathetic Discharge

Catecholamine surge from:

  • Hypothalamus
  • Medulla
  • Adrenal medulla

3️⃣ Hemodynamic Effects

  • Intense systemic vasoconstriction
  • Sudden afterload
  • Blood shifts from systemic to pulmonary circulation
  • Pulmonary capillary hydrostatic pressure

4️⃣ Pulmonary Effects

  • Endothelial injury
  • Increased capillary permeability
  • Alveolar flooding
  • Protein-rich edema fluid


Two Main Theories

A. Hydrostatic (Blast Theory)

Sudden catecholamine surge pulmonary capillary pressure transudation.

B. Permeability Theory (Now Favored)

Direct catecholamine-mediated endothelial injury increased permeability exudative edema (ARDS-like).

Modern understanding: Mixed hydrostatic + permeability mechanism.


5️⃣ Common Causes

1. Subarachnoid Hemorrhage

2. Traumatic Brain Injury

3. Intracerebral Hemorrhage

4. Status Epilepticus

5. Brainstem Lesions

  • Medullary compression
  • Posterior fossa mass


6️⃣ Clinical Presentation

Timeline:Within minutes–hours of CNS insult.

Symptoms:

  • Acute dyspnea
  • Pink frothy sputum
  • Severe hypoxemia
  • Tachypnea

Signs:

  • Bilateral crackles
  • Tachycardia
  • Hypertension (early)
  • Possible hypotension later
  • No signs of LV failure


7️⃣ Investigations

Chest X-Ray

Findings:

  • Bilateral alveolar infiltrates
  • Usually no cardiomegaly
  • Rapid radiographic resolution (24–72 hrs)

 Echocardiography

  • Normal LV systolic function
  • No cardiogenic cause

 ABG

  • Severe hypoxemia
  • Low PaO₂/FiO₂ ratio
  • May meet ARDS criteria

BNP-Usually normal or mildly elevated.


8️⃣ Differential Diagnosis

Condition

Differentiation

Cardiogenic pulmonary edema

LV dysfunction, cardiomegaly

ARDS

Sepsis/trauma cause, slower onset

Aspiration

Witnessed event

Fluid overload

Positive balance

Transfusion-related acute lung injury (TRALI)

Recent transfusion


9️⃣ Diagnostic Criteria 

Acute CNS insult
Acute respiratory distress
Bilateral infiltrates
No primary cardiac cause
Rapid improvement (often)


🔟 Management 

A.  Airway & Oxygenation

  • High-flow oxygen
  • Early intubation if:
    • GCS < 8
    • Severe hypoxemia
    • Respiratory fatigue


B. Mechanical Ventilation Strategy

Follow ARDS principles:

Parameter

Recommendation

Tidal Volume

6 ml/kg PBW

PEEP

Moderate

Plateau Pressure

< 30 cm HO

Driving Pressure

< 15

But balance with ICP control.

C.Hemodynamic Control

Early phase:Hypertension due to catecholamines

Avoid:Excessive vasodilators (risk CPP)

Maintain:Adequate MAP to preserve CPP


D. Diuretics

  • Furosemide often used
  • Useful if hydrostatic component present
  • Not mandatory in all cases


E. Treat Raised ICP

  • Head elevation 30°
  • Osmotherapy (mannitol / hypertonic saline)
  • Avoid hypoxia, hypercarbia
  • Control seizures


F. Role of Beta-Blockers?

Theoretical benefit (attenuate catecholamine surge)
Not standard guideline therapy.


1️⃣1️⃣  Prognosis

  • Often resolves in 24–72 hours
  • Mortality depends on:
    • Severity of primary CNS injury
    • Degree of hypoxemia
  • Independent predictor of worse neurological outcome in SAH